| Original language | English (US) |
|---|---|
| Pages (from-to) | 51-53 |
| Number of pages | 3 |
| Journal | Parkinsonism and Related Disorders |
| Volume | 102 |
| DOIs | |
| State | Published - Sep 2022 |
Keywords
- Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia
- CSF1R
- CSF1R-related leukoencephalopathy
- Colony-stimulating factor 1 receptor
ASJC Scopus subject areas
- Neurology
- Geriatrics and Gerontology
- Clinical Neurology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Parkinsonism and Related Disorders, Vol. 102, 09.2022, p. 51-53.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - A novel CSF1R variant in a South Dakota family with CSF1R-related leukoencephalopathy
AU - Ali, Shan
AU - Tipton, Philip W.
AU - Koga, Shunsuke
AU - Middlebrooks, Erik H.
AU - Josephs, Keith A.
AU - Strongosky, Audrey
AU - Dickson, Dennis W.
AU - Wszolek, Zbigniew K.
N1 - Funding Information: None reported. This research was supported by Mayo Clinic in Florida Focused Research Team Program, Funding Information: Z.K.W. is partially supported by the NIH/NIA and NIH/NINDS ( 1U19AG063911 , FAIN: U19AG063911 ), Mayo Clinic Center for Regenerative Medicine , Mayo Clinic in Florida Focused Research Team Program , gifts from the Sol Goldman Charitable Trust , and the Donald G. and Jodi P. Heeringa Family, the Haworth Family Professorship in Neurodegenerative Diseases Fund , and the Albertson Parkinson's Reuter Foundation . He serves as PI or Co-PI on Biohaven Pharmaceuticals, Inc. ( BHV4157-206 and BHV3241-301 ), Neuraly, Inc. ( NLY01-PD-1 ), and Vigil Neuroscience, Inc. ( VGL101–01.001 ) grants. He serves as Co-PI of the Mayo Clinic APDA Center for Advanced Research and as an external advisory board member for Vigil Neuroscience, Inc.; SA has nothing to disclose. E.H.M. receives unrelated research support paid to institution from Varian Medical Systems, Inc. and Boston Scientific Corp. E.H.M. is a consultant for Boston Scientific Corp. KAJ is funded by the National Institute of Health . The other authors report no financial disclosures. Funding Information: Z.K.W. is partially supported by the NIH/NIA and NIH/NINDS (1U19AG063911, FAIN: U19AG063911), Mayo Clinic Center for Regenerative Medicine, Mayo Clinic in Florida Focused Research Team Program, gifts from the Sol Goldman Charitable Trust, and the Donald G. and Jodi P. Heeringa Family, the Haworth Family Professorship in Neurodegenerative Diseases Fund, and the Albertson Parkinson's Reuter Foundation. He serves as PI or Co-PI on Biohaven Pharmaceuticals, Inc. (BHV4157-206 and BHV3241-301), Neuraly, Inc. (NLY01-PD-1), and Vigil Neuroscience, Inc. (VGL101–01.001) grants. He serves as Co-PI of the Mayo Clinic APDA Center for Advanced Research and as an external advisory board member for Vigil Neuroscience, Inc.; SA has nothing to disclose. E.H.M. receives unrelated research support paid to institution from Varian Medical Systems, Inc. and Boston Scientific Corp. E.H.M. is a consultant for Boston Scientific Corp. KAJ is funded by the National Institute of Health. The other authors report no financial disclosures.
PY - 2022/9
Y1 - 2022/9
KW - Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia
KW - CSF1R
KW - CSF1R-related leukoencephalopathy
KW - Colony-stimulating factor 1 receptor
UR - http://www.scopus.com/inward/record.url?scp=85135927941&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85135927941&partnerID=8YFLogxK
U2 - 10.1016/j.parkreldis.2022.07.016
DO - 10.1016/j.parkreldis.2022.07.016
M3 - Letter
C2 - 35940158
AN - SCOPUS:85135927941
SN - 1353-8020
VL - 102
SP - 51
EP - 53
JO - Parkinsonism and Related Disorders
JF - Parkinsonism and Related Disorders
ER -